We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$75.1B
AUM Growth
+$5.64B
Cap. Flow
+$2.6B
Cap. Flow %
3.46%
Top 10 Hldgs %
45.24%
Holding
2,898
New
250
Increased
1,458
Reduced
767
Closed
254

Sector Composition

Rank Sector Weight
1 Technology 5.17%
2 Financials 2.88%
3 Consumer Discretionary 1.69%
4 Healthcare 1.58%
5 Consumer Staples 1.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGY icon
2451
Vaalco Energy
EGY
$594M
$42.2K ﹤0.01%
+11,224
New +$45.8K
UGP icon
2452
Ultrapar
UGP
$6.87B
$41.6K ﹤0.01%
+10,588
New +$34.9K
GPRO icon
2453
GoPro
GPRO
$116M
$41.4K ﹤0.01%
+10,005
New +$42.9K
SMMT icon
2454
Summit Therapeutics
SMMT
$10.6B
$41.2K ﹤0.01%
16,430
+3,822
+30% +$6.97K
SABS icon
2455
SAB Biotherapeutics
SABS
$268M
$39.4K ﹤0.01%
4,752
HLGN
2456
DELISTED
Heliogen, Inc.
HLGN
$39.3K ﹤0.01%
4,589
-103
-2% -$944
VAPO
2457
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$38.9K ﹤0.01%
10,930
MKFG
2458
DELISTED
Markforged Holding Corporation
MKFG
$38.7K ﹤0.01%
+3,196
New +$30.1K
EXK
2459
Endeavour Silver
EXK
$2.32B
$38.1K ﹤0.01%
13,171
-12,800
-49% -$45.2K
SWIM icon
2460
Latham Group
SWIM
$646M
$37.8K ﹤0.01%
10,177
+177
+2% +$541
JD icon
2461
CALL
JD.com
JD
$40.8B
$37.5K ﹤0.01%
20,000
+19,800
+9,900% +$720K
OTLK icon
2462
Outlook Therapeutics
OTLK
$264M
$37.4K ﹤0.01%
1,075
-75
-7% -$2.04K
MIST icon
2463
Milestone Pharmaceuticals
MIST
$144M
$37.3K ﹤0.01%
13,080
KNTE
2464
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$37.1K ﹤0.01%
+12,257
New +$47.3K
GLDG
2465
GoldMining Inc
GLDG
$179M
$36.4K ﹤0.01%
40,421
FTEK icon
2466
Fuel Tech
FTEK
$48M
$36.2K ﹤0.01%
27,350
IAG icon
2467
IAMGOLD
IAG
$8.47B
$35.6K ﹤0.01%
13,524
-582,500
-98% -$1.69M
VXRT
2468
DELISTED
Vaxart
VXRT
$35.4K ﹤0.01%
48,500
-250
-0.5% -$232
DHC
2469
Diversified Healthcare Trust
DHC
$2.26B
$34.6K ﹤0.01%
15,380
-1,816
-11% -$2.61K
SOND
2470
DELISTED
Sonder
SOND
$33.7K ﹤0.01%
3,176
BCLI
2471
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$33.2K ﹤0.01%
1,076
+143
+15% +$5.93K
VRM icon
2472
Vroom Inc
VRM
$36.9M
$31.6K ﹤0.01%
274
+126
+85% +$9.6K
XXII
2473
22nd Century Group
XXII
$1.47M
0
CGC
2474
Canopy Growth
CGC
$375M
$30.8K ﹤0.01%
7,932
-795
-9% -$8.34K
SPY icon
2475
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$30.3K ﹤0.01%
9,300
+6,300
+210% +$2.64M

Similar funds

Creative Planning's Q2 2023 Portfolio in Review

As of Q2 2023, Creative Planning held 2,898 positions worth $75.1B, up 8.1% from $69.4B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Creative Planning deployed $2.6B of net new capital in Q2 2023, opening 250 new positions and adding to 1,458 existing holdings. Its largest new stake was United Homes Group: 388,000 shares worth $4.33M.

By sector, the portfolio is most concentrated in Technology at 5.2% of assets, up from 4.7% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $117M trimmed.

  • Creative Planning's largest Q2 2023 buy was United Homes Group: 388,000 shares worth $4.33M.
  • Creative Planning added most to Vanguard Total Bond Market in Q2 2023, an estimated $495M increase.
  • Creative Planning's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $117M.
  • Creative Planning fully exited PIMCO 15+ Year US TIPS Index Exchange-Traded Fund in Q2 2023, selling an estimated $2.75M.
  • Creative Planning's ten largest holdings make up 45% of its $75.1B portfolio in Q2 2023.
  • Creative Planning opened 250 new positions and closed 254 in Q2 2023.
  • Creative Planning's portfolio value rose 8.1% quarter-over-quarter to $75.1B.

Based on Creative Planning's 13F filing for Q2 2023, filed 21 Jul 2023.